Role of peroxiredoxin III in the pathogenesis of pre-eclampsia as evidenced in mice

Oxidative Medicine and Cellular Longevity

Volumn 3, Issue 1, 2010, Pages 71-73

  Li, Lianqin ^a   Obinata, Masuo ^b   Hori, Katsuyoshi ^b  

^a TSINGHUA UNIVERSITY YUQUAN HOSPITAL   (China)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

Hypertension; Mouse; Oxidative stress; Peroxiredoxin; Placenta; Pre eclampsia; Reactive oxygen species

Indexed keywords

ENDOTHELIN 1; PEROXIREDOXIN; PEROXIREDOXIN 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MEASUREMENT; CAROTID ARTERY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; LIPID PEROXIDATION; MATERNAL HYPERTENSION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PLACENTA; PREECLAMPSIA; PREGNANCY; RISK FACTOR; WESTERN BLOTTING; WILD TYPE;

MUS;

EID: 77953471548     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.4161/oxim.3.1.10094     Document Type: Article

References (18)

1. Qanungo S, Mukherjea M. Ontogenic profile of some antioxidants and lipid peroxidation in human placental and fetal tissues. Mol Cell Biochem 2000; 215:11-9.
2. Carone D, Loverro G, Greco P, Capuano F, Selvaggi L. Lipid peroxidation products and antioxidant enzymes in red blood cells during normal and diabetic pregnancy. Eur J Obstet Gynecol Reprod Biol 1993; 51:103-9.
3. Rabilloud T, Heller M, Rigobello MP, Bindoli A, Aebersold R, Lunardi J. The mitochondrial antioxidant defence system and its response to oxidative stress. Proteomics 2001; 1:1105-10.
4. Ejima K, Nanri H, Araki M, Koji T, Shibata E, Kashimura M, et al. Expression of mitochondrial thioredoxin-dependent antioxidant protein, SP-22, in normal human and inflammatory mouse placentae. Placenta 2000; 21:847-52.
5. Shibata E, Nanri H, Ejima K, Araki M, Fukuda J, Yoshimura K, et al. Enhancement of mitochondrial oxidative stress and upregulation of antioxidant protein peroxiredoxin III/SP-22 in the mitochondria of human pre-eclamptic placentae. Placenta 2003; 24:698-705.
6. Li L, Shoji W, Oshima H, Obinata M, Fukumoto M, Kanno N. Crucial role of peroxiredoxin III in placental antioxidant defense of mice. FEBS Lett 2008; 582:2431-4.
7. Wang Y, Walsh SW. TNFalpha concentrations and mRNA expression are increased in preeclamptic placentas. J Reprod Immunol 1996; 32:157-69.
8. Morikawa S, Kurauchi O, Tanaka M, Yoneda M, Uchida K, Itakura A, et al. Increased mitochondrial damage by lipid peroxidation in trophoblast cells of preeclamptic placentas. Biochem Mol Biol Int 1997; 41:767-75.
9. Shibata E, Ejima K, Nanri H, Toki N, Koyama C, Ikeda M, et al. Enhanced protein levels of protein thiol/disulphide oxidoreductases in placentae from preeclamptic subjects. Placenta 2001; 22:566-72.
10. Gupta S, Agarwal A, Sharma RK. The role of placental oxidative stress and lipid peroxidation in preeclampsia. Obstet Gynecol Surv 2005; 60:807-16.
11. Li L, Shoji W, Takano H, Nishimura N, Aoki Y, Takahashi R, et al. Increased susceptibility of MER5 (peroxiredoxin III) knockout mice to lipopolysaccharide (LPS)-induced oxidative stress. Biochem Biophys Res Commun 2007; 355:715-21.
12. Hori K, Saito S. Microvascular mechanisms by which the combretastatin A-4 derivative AC7700 (AVE8062) induces tumour blood flow stasis. Br J Cancer 2003; 89:1334-44.
13. Roberts JM, Lain KY. Recent insights into the pathogenesis of pre-eclampsia. Placenta 2002; 23:359-72.
14. Hoffmann DS, Weydert CJ, Lazartigues E, Kutschke WJ, Kienzle MF, Leach JE, et al. Chronic tempol prevents hypertension, proteinuria and poor fetoplacental outcomes in BPH/5 mouse model of preeclampsia. Hypertension 2008; 51:1058-65.
15. Hung TH, Skepper JN, Charnock-Jones DS, Burton GJ. Hypoxia-reoxygenation: a potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia. Circ Res 2002; 90:1274-81.
16. Hung TH, Skepper JN, Burton GJ. In vitro ischemiareperfusion injury in term human placenta as a model for oxidative stress in pathological pregnancies. Am J Pathol 2001; 159:1031-43.
17. Hung TH, Charnock-Jones DS, Skepper JN, Burton GJ. Secretion of tumor necrosis factor-alpha from human placental tissues induced by hypoxia-reoxygenation causes endothelial cell activation in vitro: a potential mediator of the inflammatory response in preeclampsia. Am J Pathol 2004; 164:1049-61.
18. Fiore G, Florio P, Micheli L, Nencini C, Rossi M, Cerretani D, et al. Endothelin-1 triggers placental oxidative stress pathways: putative role in preeclampsia. J Clin Endocrinol Metab 2005; 90:4205-10.